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Regulatory Role for the Profilaggrin N-Terminal
Domain in Epidermal Homeostasis
Sirpa Aho1, Clive R. Harding2, Jian-Ming Lee1, Helen Meldrum1 and Carol A. Bosko1
It is well known that profilaggrin, after its release from keratohyalin granules through dephosphorylation,
becomes enzymatically processed into individual filaggrin monomers. The roles for filaggrin monomers in
aggregating keratin filaments, as a component of the cornified cell envelope, and as a source of natural
moisturizing factor are well established. A specific N-terminal fragment, called the PF-AB domain, becomes
proteolytically released as well, but much less is known about its functional role in epidermal development.
Here, the functional role of profilaggrin N-terminal (PF-N) domain was addressed by overexpressing three
overlapping fragments from a lentiviral expression vector in the epidermis of living skin equivalents. The PF-N
domain expression impaired the epidermal development through reducing keratinocyte proliferation and
impairing differentiation. The expression of well-known differentiation markers profilaggrin, loricrin, and
keratin 10 was considerably downregulated in PF-N domain overexpressing–skin equivalents. The activation of
caspase 14 was also substantially affected. In contrast, total silencing of profilaggrin expression, obtained with a
lentiviral miR vector, resulted in a hyperproliferative epidermis. We propose a hypothesis that profilaggrin AB
domain provides a key feedback mechanism that controls epidermal homeostasis.
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INTRODUCTION
Profilaggrin is a late epidermal differentiation marker,
synthesized by granular cell layer keratinocytes. During the
late stages of epidermal terminal differentiation, profilaggrin
becomes dephosphorylated, is released from keratohyalin
granules, and is proteolytically cleaved into 10–12 filaggrin
monomers. The role for filaggrin monomers as aggregating
keratin filaments, as a component of cornified cell envelope,
and as a source of free amino acids for the natural
moisturizing factor has been well established (Brown and
McLean, 2012). The role of filaggrin in normal skin was
further emphasized through analysis of mutations in the gene
encoding profilaggrin. Loss-of-function mutations were found
to underlie a dry skin disease Ichthyosis vulgaris (Smith et al.,
2006) and to be a major predisposing factor for atopic
dermatitis (Palmer et al., 2006), supporting an earlier
observation on the correlation between dry skin phenotype
and a distinct combination of filaggrin repeats 10, 11, and 12
(Ginger et al., 2005). Recently, a large-scale study proved that
intragenic copy number variation within the filaggrin gene
contributes to the risk of atopic dermatitis, the lower number
of filaggrin repeats affecting the composition and compromising
the quality of the stratum corneum, and thus increasing
atopic dermatitis risk (Brown et al., 2012).
Profilaggrin, together with trichohyalin, repetin, cornulin,
and hornerin, belongs to a group of large multidomain
proteins called the fused S100 proteins (Wu et al., 2009). The
S100 proteins are characterized by the presence of two
calcium-binding EF-hand motifs (Marenholz et al., 2004).
Because calcium acts as a second messenger to regulate
keratinocyte proliferation and differentiation, S100 proteins
in the epidermis are of great interest as mediators of calcium-
associated signal transduction (Broome et al., 2003). A
distinct N-terminal fragment of profilaggrin, the PF-AB
domain, is proteolytically released from profilaggrin (Pres-
land et al., 1997). Sequence analysis has indicated that the
profilaggrin A domain contains a calcium-binding S100-like
EF-hand motif (Presland et al., 1992, 1995). The cationic B
domain of profilaggrin contains a bipartite nuclear localiza-
tion signal, which is responsible for the nuclear localization
of the PF-AB domain in terminally differentiated keratino-
cytes (Zhang et al., 2002). Nuclear localization of the
profilaggrin N terminus has been observed to precede the
event of keratinocytes losing their nuclei and transforming
into corneocytes to form the stratum corneum (Ishida-
Yamamoto et al., 1998), suggesting a critical role for this
peptide in the later stages of terminal differentiation. Its
involvement in differentiation is further supported by a recent
study reporting the interactions with cornified envelope–
associated proteins and keratin 10 (Yoneda et al., 2012).
Additional studies on the nuclear localization of profilaggrin
N-terminal peptide were conducted using the transiently
transfected keratinocytes in monolayer culture (Pearton et al.,
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2002). A GFP-tagged PF-AB domain was observed almost
exclusively in the nuclei, but the AB domain, either when
connected to the truncated filaggrin repeat or represented
as shortened or mutated variants of the PF-AB domain,
generated through site-directed mutagenesis of the nuclear
localization signal within the B domain, were only observed
in a diffuse cytoplasmic localization.
Although profilaggrin loss-of-function mutations eliminate
the granular cell layer by abolishing keratohyalin granules
and filaggrin monomers from the epidermis (Nirunsuksiri
et al., 1995), a truncated profilaggrin has been detected in the
epidermis of human Ichthyosis vulgaris patients (Sandilands
et al., 2006, 2007; Smith et al., 2006), as well as in the flaky
tail mouse (Presland et al., 2000; Fallon et al., 2009). In all
these cases, the S100-like AB domain may remain functional
in differentiating keratinocytes.
To better understand the role of the profilaggrin N
terminus in the epidermis, we used a living skin equivalent
(LSE) model, composed of human dermal fibroblasts and
lentivirus-infected primary adult human keratinocytes. Here
we describe the consequences of the overexpression of
profilaggrin N-terminal (PF-N) domain on epidermal prolif-
eration and development.
RESULTS
Tagged profilaggrin AB domain localizes into keratinocyte
nuclei and is expressed in the granular cell layer of the
epidermis
To obtain stable expression of the profilaggrin domains we
used a lentiviral expression system and we first expressed V5-
tagged PF-N domains in primary keratinocytes in monolayer
culture (Figure 1). Western blotting revealed the V5-tagged
polypeptides with the expected size expressed in keratino-
cytes transiently transfected with lentiviral destination plas-
mids. V5-tagged proteins in primary keratinocytes in
monolayer culture were visualized through indirect immuno-
fluorescence. The V5-tagged A domain, spanning PF-N
domain amino-acid residues (aa) 1–80, was present as diffuse
staining. The V5-tagged AB domain, aa 1–295, was detected
both in the nuclei and in cytoplasmic granules. The B domain
is known to contain a nuclear localization signal (Pearton
et al., 2002; Zhang et al., 2002), which can direct the AB
domain into the nucleus. The ABTF domain, aa 1–591, was
rarely seen in the nucleus, but instead was observed in the
cytoplasmic granules. The ABTF domain construct encodes a
peptide composed of the A and B domains, a truncated
filaggrin repeat, and 125-aa residues of the first filaggrin
monomer repeat. The truncated filaggrin repeat attached to
the AB domain has been observed to prevent the nuclear
localization of the N-terminal domain (Pearton et al., 2002).
The ABTF peptide closely resembles the N-terminal peptide,
generated in patient cells with the R501X filaggrin gene
mutation (Smith et al., 2006).
Staining for the Lumio-tag expression revealed a 30–40%
transduction efficiency in HaCaT monolayer cultures. Closer
examination of HaCaT cultures transfected with the AB domain
expression vector revealed fewer AB domain–expressing cells
as compared with the A domain and ABTF domain–expressing
cultures and a GFP-expressing control (Supplementary Figure
S1 online). However, our attempts to establish an AB
domain–overexpressing HaCaT line failed. Relevant selection
of the N-terminal domain plasmids after transfection or
a
b
c d
MW (kD)
PF-ABTF
PF-AB
PF-A
100
50
37
20
15
10
PF-A
PF-AB
PF-ABTF
PF-AB
PF-ABTF
PF-A
V5-tag V5-tag+DAPI
A B
A
A
A
B
B
T F
T F F
PF-ABTF 70 kD+V5 tag
PF-AB 32 kD+V5 tag
PF-A 10 kD+V5 tag
F F F F F F F F C
Figure 1. Expression of profilaggrin N-terminal domains in keratinocyte
monolayer culture from a lentiviral vector. (a) Profilaggrin N-terminal
fragments encoding A, AB, and ABTF domains were cloned into a lentiviral
expression vector containing the V5-epitope tag. (b) Western blotting of cell
lysates confirmed the expression of V5-tagged profilaggrin domains in
keratinocytes after transient transfection. (c) Immunofluorescence microscopy
of transiently transfected keratinocytes demonstrated diffuse cytoplasmic
staining for the PF-A domain, mainly nuclear but also grainy cytoplasmic
localization for the PF-AB domain, and grainy cytoplasmic localization for the
PF-ABTF domain. The nuclei were highlighted through 40,6-diamidino-2-
phenyl indole (DAPI) staining (blue signal in the right hand panels). MW,
molecular weight. Bar¼ 50 mm.
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transduction did not yield positive colonies, but instead a
gradual loss of cells was observed. Often the AB domain–ex-
pressing cells appeared as a pair of daughter cells, which did
not proceed to produce progenitors and form colonies
(Supplementary Figure S1 online). We speculated that either
a premature terminal differentiation or a block of cell
proliferation was exhausting the cells overexpressing the AB
domain.
Overexpression of PF N-terminal domains in LSE cultures
prevents keratinocyte proliferation and impairs epithelial
differentiation
The results shown here are representatives of four separate
experiments of lentivirus-transduced LSEs with six replicates
in each run. Keratinocytes from two donors were used here.
In addition to the mock-transduced control, LSEs infected
with lentiviral particles overexpressing LacZ or GFP were
prepared as controls. In all controls, the overall epidermal
morphology and the expression of the molecular markers
appeared similar.
To explore the impact of PF domains on epidermal
proliferation and differentiation, keratinocytes were trans-
duced with lentiviral vectors, applied on the dermal
equivalents, and maintained in culture for 4–11 days after
air exposure. Examination of the hematoxylin and eosin–-
stained sections revealed poor development of the epidermis
in LSEs grown from keratinocytes expressing A, AB, and ABTF
domains (Figure 2). Compared with the control cultures, there
were fewer cells within the basal cell layer, spinous cell layer
keratinocytes were compressed, and there were fewer
corneocyte layers forming the stratum corneum. Similar to
what was seen in the monolayer transfection, PF A domain
showed diffuse localization, whereas the AB and ABTF
domains showed granular and occasionally nuclear staining,
which was seen in all experiments. Although the Lumio
staining highlighted the expression of the recombinant
proteins in monolayer cell culture, it gave strong nonspecific
staining throughout the epidermis of the LSE cultures, and
could not be used with LSE sections (Supplementary Figure
S1 online). Instead, the V5-tag was used to detect transgene
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Figure 2. Number of proliferating keratinocytes in the living skin equivalents (LSEs) overexpressing profilaggrin N-terminal fragments. LSEs were grown from
lentivirally infected keratinocytes and samples collected 7 days after air exposure. (a) Immunohistochemistry (IHC) with V5 antibody revealed the
PF-N domain expression in the upper epidermis. (b) Ki67 staining in the control culture with no virus, in LacZ-overexpressing control, and in the PF-A-,
PF-AB-, and PF-ABTF-expressing cultures. (c) E-cadherin staining of the epidermis. IHC of donor 1 shown. Bar¼100 mm, applies to all images. (d) Number of
Ki67-positive cells counted from 15 independent 700-mm sections (donor 1) or 25 sections (donor 2), mean±SD. The difference between A, AB, and ABTF
domains and the control was significant by using the t-test (*Po0.001).
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expression in the LSE-cultures. The expression of the V5-
tagged PF-N domains from a lentiviral vector, not containing
the posttranscriptional regulatory element of woodchuck
hepatitis virus, was seen mainly in the upper layers of the
epidermis, where the endogenous profilaggrin is typically
located (Figure 2a). The lentiviral vectors have been shown to
direct the transgene expression from a CMV promoter to the
upper epidermis (Zufferey et al., 1999; Ghazizadeh et al.,
2004), but including the woodchuck hepatitis virus regulatory
element enhanced the transgene expression in the basal
keratinocytes (Zufferey et al., 1999; Ghazizadeh et al., 2004).
The epidermis is replenished through keratinocyte pro-
liferation in the basal cell layer. We used Ki67 as a marker to
identify proliferating cells (Figure 2b). Whereas the control
cultures revealed a regular appearance of Ki67-positive cells
within the basal cell layer, the PF A, PF AB, and PF ABTF
domain–expressing LSEs contained fewer and irregularly
spaced Ki67-positive cells. Counting the Ki67-positive cells
from LSEs grown from two adult donor keratinocytes
confirmed a significant reduction in cell proliferation by the
PF-N domain (Figure 2d). Interestingly, a two-fold difference
in the number of proliferating cells in the control LSEs
between the two donors reflects the difference in the growth
rate, which we have observed in the monolayer cultures (data
not shown). The epidermal thinning, especially in the PF AB
domain–expressing cultures, was emphasized through
E-cadherin staining (Figure 2c).
Because it had been hypothesized that the profilaggrin AB
domain promotes terminal differentiation of keratinocytes,
it was of interest to determine the status of differentiation
markers in the LSE-cultures overexpressing the PF N-terminal
fragments. First, both profilaggrin and loricrin were down-
regulated in the cultures overexpressing the N-terminal
domains (Figure 3a and b). The viable epidermis appeared
considerably thinner in these cultures when compared with
the control cultures. The impact of the PF N domain on the
expression of differentiation markers was further character-
ized through analyzing the protein extracts on the western
blots, which clearly demonstrated the time-dependent
maturation of the LSE cultures (Figure 3c). In the control
cultures, at day 4 post air exposure, mainly high-molecular-
weight profilaggrin was observed, by day 7 filaggrin
monomers appeared, and by day 12 mainly intermediate
processing products could be detected. When normalized
against total protein, the expression of E-cadherin and keratin
14 was not substantially affected by PF N domains. However,
the overexpression of the PF N-terminal domains impaired
the expression of the differentiation-specific proteins, profi-
laggrin, keratin 10, and caspase 14. Non-cross-linked soluble
involucrin was increased as compared with the control
cultures, suggesting a deficiency in the expression of
transglutaminases (Figure 3d).
These results suggested that instead of promoting differ-
entiation the overexpression of the AB domain actually
impairs that process. Because the number of proliferating
cells was significantly reduced, the epidermis was formed by
fewer keratinocytes, resulting in a thin and flat epidermis
when compared with the control cultures. We concluded that
prevention of hyperproliferation by blocking keratinocyte
proliferation may represent the primary function of the
profilaggrin N-terminal domain.
Profilaggrin silencing results in thickened epidermis
To confirm or refute a possible role of the PF N-terminal
sequence on proliferation and differentiation, we used a
lentiviral miR construct designed to target profilaggrin
mRNA sequences and eliminate profilaggrin expression from
the epidermis in the LSE cultures. The lentiviral miR infection
indeed quantitatively abolished profilaggrin, filaggrin, and
the intermediate processing products in the LSEs (Figure 4a
and b, Supplementary Figure S2 online). Compared with the
control LSEs with a nontargeting miR, the profilaggrin
knockdown epidermis started to develop normally. How-
ever, at the later time points, there was substantial thickening
of the epidermal compartment, and a dense population of
small undifferentiated keratinocytes was seen within the
basal and immediate suprabasal layers. In the control LSEs,
only a single layer of keratin 10–negative, nondifferentiated
basal keratinocytes was observed (Figure 4b and c). Keratin
14 and E-cadherin, as well as b-catenin and soluble
involucrin, remained constant (Supplementary Figure S2
online). The expression of keratin 10 and procaspase 14
increased from day 7 to day 11, but there was no difference
between the scrambled and PF-targeting lentiviruses. How-
ever, more than 2-fold increase was seen in keratin 16
protein and in the appearance of cleaved caspase 14 in the
knockdown culture at day 11 (Figure 4a, Supplementary
Figure S2 online).
DISCUSSION
Given its unique structure and localization within the
uppermost viable epidermal layer and the rapid but carefully
controlled proteolysis, many researchers have tried to define
functional significance to the different cleaved elements
derived from the profilaggrin molecule. Filaggrin gene
mutations have been shown to result in the reduction or
total absence of filaggrin monomers in the epidermis. The
N-terminal AB domain is released from profilaggrin through
the action of proteolytic enzymes, including furin, matriptase,
and prostasin (Pearton et al., 2001; List et al., 2003; Leyvraz
et al., 2005). The cleavage of the AB domain takes place
independently from the release of filaggrin monomers
(Pearton et al., 2001), and it has been demonstrated by
western blotting and through immunohistochemistry (IHC)
both in the normal epidermis and in the Ichthyosis vulgaris
patients (Presland et al., 2000; Smith et al., 2006; Sandilands
et al., 2007). The AB domain has been detected in the nuclei
with fragmented DNA, and thus it was originally suggested to
promote keratinocyte denucleation and cornification (Ishida-
Yamamoto et al., 1998). This observation led us to undertake
the development of an LSE model system in which to test the
hypothesis that the AB domain provides a key signal for
keratinocyte differentiation in the epidermis. Instead, our
results revealed the arrest of proliferation by the AB domain
and prominent hyperproliferation in the profilaggrin-negative
epidermis (Figure 5).
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Early on, when trying to establish an AB domain–overex-
pressing keratinocyte population in monolayer culture, we
observed a persistent loss of the AB domain–overexpressing
cells, suggesting an inhibitory role for the AB domain in
keratinocyte proliferation. When using HaCaT cells, we
observed that the Lumio-tagged AB domain induced a cell
cycle arrest, which resulted in two daughter cells in close
proximity, but did not allow infected cells to form colonies. It
is possible that HaCaT cells lack specific enzymes necessary
for proper processing of the PF N-terminus, especially when
the ABTF domain showed strong response in the LSEs grown
from primary keratinocytes. In the LSEs grown from kerati-
nocytes infected with the A, AB, and ABTF domain–overex-
pressing lentivirus, we observed a significant decrease in the
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Figure 3. Differentiation of the epidermis is compromised by the overexpression of profilaggrin N-terminal fragments. The expression of the differentiation
markers (a) filaggrin and (b) loricrin was decreased in the PF-N domain–overexpressing living skin equivalents (LSEs), shown at 7 days (d) post air exposure.
Bar¼100 mm, applies to all images. (c) LSE extracts were normalized against the protein content (5 mg protein per lane), separated on 4–20% PAGE, and the
selected epidermal proteins were detected with specific antibodies. E-cadherin and keratin 14 were not affected by the PF-N domain expression. (d) When
normalized against K14, the AB domain had the highest impact on K10, as well as on profilaggrin and caspase 14 expression at the 12-day time point, whereas
the soluble involucrin was increased in all PF N-terminal fragments overexpressing LSEs. AL, air exposure.
Figure 4. Silencing of profilaggrin gene expression in living skin equivalents (LSEs) results in a hyperproliferative epidermis. (a) Western blotting with
profilaggrin antibody revealed nearly quantitative knockdown of profilaggrin expression by a specific lentiviral miR. Caspase 14 expression and activation was
not inhibited. (b) Immunohistochemistry (IHC) with filaggrin antibody confirmed a complete knockdown of profilaggrin expression. (c) Keratin 10 is present in
the differentiated keratinocytes. Non-differentiated basal cell layer is one-cell thick in the control cultures, but consists of multiple cell layers especially in the
11-day knockdown culture. All sections were counterstained with hematoxylin. Bar¼ 100mm. AL, air exposure.
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number of Ki67-positive proliferating cells. In addition, we
observed a substantial inhibition in the expression of
differentiation markers in these LSEs, but this response may
be a consequence of the defective cell proliferation rather
than the primary effect. On the basis of the results from both
monolayer and LSE cultures, we concluded that prevention of
hyperproliferation by blocking keratinocyte proliferation may
represent the primary function of the PF-N domain. The
decrease in differentiation markers that we observed may
have resulted from an insufficient number of keratinocytes for
the proper epidermal development and differentiation of the
LSE cultures.
The profilaggrin AB domain contains a functional calcium-
binding domain, homologous to that of the S100-family of
proteins (Markova et al., 1993), and thus it is tempting to
speculate that this domain has biological functions similar to
other S100 proteins (Marenholz et al., 2004). Changes in the
level of calcium-binding proteins may alter the calcium
gradient in the epidermis by regulating the ratio of free versus
bound intracellular calcium (Celli et al., 2011) and conse-
quently triggering a signaling mechanism affecting epidermal
homeostasis. Profilaggrin and another fused type S100-
protein hornerin, are present at high levels in the normal
epidermis, but are substantially downregulated in psoriasis
(Takaishi et al., 2005; Huffmeier et al., 2007; Zhao et al.,
2007), which is consistent with our observation on profilag-
grin playing an inhibitory role on keratinocyte proliferation.
To further investigate this hypothesis, we performed a total
knockdown of profilaggrin. The lentiviral miR-mediated gene
silencing resulted in near complete profilaggrin knockdown
in LSEs, characterized by an absence of keratohyalin granules
and a thickened epidermis with substantially increased
proliferating cell layers. Barrier disruption either through
tape stripping or after chemical or UV insult has been shown
to stimulate keratinocyte proliferation and enhance expres-
sion of cytokines (Scott, 1986; Wood et al., 1992). More
recently, filaggrin loss-of function mutations have been
associated with enhanced expression of IL-1 cytokines (Kezic
et al., 2012). Elevated cytokine levels, epidermal thickening,
and cutaneous inflammation, when exposed to an allergen,
were measured in a flaky tail mouse (Fallon et al., 2009). In
our study, we observed an increase in keratin 16 expression,
which is a marker of keratinocyte proliferation and increased
migration (Paladini et al., 1996). In our study, active caspase
14, which is required for filaggrin degradation in skin
(Denecker et al., 2007; Hoste et al., 2011), was increased
more than 2-fold at the 11-day time point. Our results clearly
demonstrate that the loss of barrier function generated by
filaggrin knockdown is associated with a wound healing
response as evidenced by an increase in inflammatory
markers, i.e., keratin 16 and Ki67. This observation, however,
is in contrast to the results of Mildner et al. (Mildner et al.,
2010) who reported that knockdown of profilaggrin in the LSE
cultures was associated with reduced barrier function,
although no effect on proliferation or epidermal thickness
was reported. This difference in results may be explained by
the fact that Mildner et al. used stealth oligonucleotides for
profilaggrin silencing. It is possible that the short growth
period of LSEs in those studies (total of 7 days) was not
sufficient to reveal the hyperproliferative phenotype. Because
the lentivirus incorporates stably into the cell genome, we
were able to grow the LSEs first submerged for first 6 days
followed by air exposure for further 4, 7, or 11 days. We
observed prominent hyperproliferation at the 11-day time
point, which corresponds to a total of 17 days in culture.
Considering the epidermal turnover time, the average time
from cell division in the basal cell layer to desquamation at
the skin surface, calculated to be 47–48 days (Iizuka, 1994),
the longer culture period should better reflect the physiolo-
gical homeostasis of the epidermis. In agreement with the
results reported by Mildner et al., we did not observe
profilaggrin knockdown altering the differentiation markers in
the LSE cultures. In contrast, a recent study utilizing the raft
culture keratinocyte system demonstrated significant loss of
loricrin expression and some reduction in K10 expression as a
consequence of an adenoviral vector–mediated profilaggrin
silencing (Yoneda et al., 2012). Although adenoviral knock-
down is expected to provide a longer-term knockdown of
gene expression, similar to our lentiviral system, Yoneda et al.
did not observe epidermal thickening. However, Yoneda
et al. did not disclose the length of the culture period or the
origin of human keratinocytes used. It is possible that
differences in time course and other experimental details
are responsible for the differences in their results versus those
presented in this paper. Ultimately, an inducible expression
system may be necessary to resolve these differences.
There are many proteins that regulate the cell cycle
positively or negatively. Interestingly, the induced over-
expression of a filaggrin monomer in a rat epidermal
keratinocyte line caused a cell cycle arrest (Presland et al.,
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Figure 5. Hypothesis on the role of profilaggrin processing products in
epidermal maintenance, controlling epidermal proliferation, and improving
barrier function and moisturization. aa, amino acid; A and B, profilaggrin
N-terminal AB domain; C, profilaggrin C terminus; F, filaggrin monomer;
PCA, pyrrolidone-5-carboxylic acid; SB, stratum basale; SC, stratum corneum;
SG, stratum granulosum; SP, stratum spinosum; T, truncated filaggrin
monomer; UCA, urocanic acid.
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2001). The mechanism was not determined, but it was
proposed that the cell cycle arrest may be related to
cytoskeletal intermediate filament disruption. From the early
70s, it has been suggested that the epidermis contains
‘‘chalones’’, which provide a negative feedback mechanism,
regulating the balance between keratinocyte proliferation
and differentiation (Elgjo, 1972; Bullough, 1973, 1975; Elgjo
and Clausen, 1983; Richter et al., 1988; Tiegel et al., 1989).
Although, to date, efforts to identify the putative epidermal
chalone(s) have not been successful, the data presented from
our studies raise the possibility that a defined fragment of the
profilaggrin protein, produced by the carefully regulated
proteolysis of this complex protein, may fulfill such a role. On
the basis of our results, we propose that the profilaggrin AB
domain released during the transition of the viable granular
layer keratinocytes into the terminally differentiated corneo-
cytes is one potential candidate for this type of feedback
mechanism for controlling the cell cycle and epidermal
homeostasis.
MATERIALS AND METHODS
Production of lentiviral overexpression and silencing constructs
Specific primers were designed based on the profilaggrin cDNA
sequence (Genbank, accession number L01089) and used for PCR
production of the A, AB, and ABTF domains: a common forward
primer 50-CACC ATG TCT ACT CTC CTG GAA AAC-3, reverse
primers for A domain 5-CTT GAA TAC CAT CAG AAG AAA CT-30
(244 bp PCR product), AB domain 50-GGA TCC CCT ACG CTT TCT
TG-30 (889 bp PCR product), and ABTF domain 50-AGC TTC ATG
ATG ACG TGA CCC TGA-30 (1,777 bp PCR product). PCR products
were cloned through pENTR/D-TOPO entry vector (Invitrogen,
Currently Life technologies, Grand Island, NY) into the pLenti6.2/
C-Lumio/V5-DEST vector, and the correct DNA sequence was
verified through DNA sequencing. Lentiviral stocks were purchased
from Invitrogen (Carlsbad, CA).
To prepare the lentiviral knockdown vector for profilaggrin, we
used Invitrogen cloning services. Sequences targeting profilaggrin
mRNA (GenBank # NM 002016) were designed using the Invitrogen
BLOCK-iT RNA Designer software. For the functional screening,
each target cassette, cloned in pcDNA 6.2-GW/miR vector, and
containingB30 nt of upstream and downstream sequences from the
region targeted by the shRNA sequence, was cloned immediately
downstream of the lacZ coding region in the pSCREEN-iT/lacZ-DEST
reporter vector. GripTite 293 MSR cells were cotransfected with
either, a miR-neg-negative control vector, a miR-lacZ-positive
control vector, or the target-specific miR RNAi construct. The
knockdown activity of each BLOCK-iTTM Pol II miR RNAi vector was
determined by normalization of b-galactosidase activities to the
negative control. On the basis of the software prediction, six target
sequences were tested and one of those resulted with a satisfactory
87% gene silencing. Lentiviral particles with pcDNA 6.2-GW/miR-
NM_002016_11884 profilaggrin silencing sequence were used for
infecting keratinocytes.
Living skin equivalents
LSEs were assembled and grown in the Transwell inserts (24mm,
3mm, Corning Life Sciences, Lowell, MA) according to the published
protocol (Margulis et al., 2005). In short, keratinocytes, 150,000
cells in 50 ml of JG-I medium, were applied on the top of 0.8 cm2 of
collagen fibroblast matrix, and the LSE cultures were grown first
submerged for 3 days in JGI medium, then for 3 days in the JGII
medium, and then at the air–liquid interface with feeding from
underneath with the JG-AL medium for the number of days as
indicated in each figure. Results shown are representatives from
several repeats of LSE cultures.
Keratinocytes from adult donors (donor 1, 4C1201; donor 2,
4C1297, 30- to 40-year-old female donors; Cascade/Invitrogen/Life
Technologies) were expanded once in Epilife with HKGS (Invitrogen)
and stored under liquid nitrogen. Passage 3 keratinocytes were used
to grow the LSEs. For the lentiviral infection, keratinocytes were
mixed in suspension with 6 ngml1 of polybrene and with lentiviral
particles (multiplicity of infection¼ 1), incubated in room tempera-
ture for 10minutes, and applied on the dermal equivalents, made
from bovine collagen (Organogenesis, Canton, MA; 1mgml1) and
human dermal fibroblasts (75,000 cells per insert) from a neonatal
donor (Invitrogen).
Primary antibodies
For the detection of V5-tag, a mouse mAb (Invitrogen; 1:1,000)
was used. Proliferating cells were visualized on the FFPE sections
with Ki67 antibody (Neomarkers/LabVision/Thermo Scientific,
Kalamazoo, MI; 1:5,000 dilution). Filaggrin was detected with
mouse mAb BTI576 (clone AKH1, Biomedical Technologies,
Stoughton, MA; 1:2,500 dilution). Caspase 14 was detected
with rabbit polyclonal antibody (Abcam, Cambridge, MA;
1:2,000), against the N-terminal amino acids 1–20, thus detecting
on the western blot the unprocessed proenzyme (29 kD) and the
cleaved small fragment (11 kD). Polyclonal rabbit loricrin antibody
(1:25,000; Abcam), monoclonal E-cadherin and b-catenin antibo-
dies (1:1,000; Transduction laboratories/BD Biosciences, San Jose,
CA), monoclonal Involucrin antibody (1:5,000; Sigma-Aldrich,
Saint Louis, MO), and Keratin 10, Keratin 14 and Keratin 16 mAbs
(1:5,000; Neomarkers/Thermo Scientific) were used for the western
blotting.
Immunofluorescence
Monolayer culture of keratinocytes was transiently transfected with
the lentiviral destination plasmids in the 4-well-chamber slides, and
grown in Epilife supplemented with HKGS (Invitrogen) and 2mM
Ca2þ for an additional 2 days after transfection. For the immuno-
detection, cells were fixed in methanol, permeabilized with 0.1%
Triton X-100, blocked with PBS, 1% BSA, and incubated with
primary antibodies overnight. V5-tag was visualized with Texas-red-
conjugated secondary antibody (Jackson ImmunoResearch, West
Grove, PA; red signal), and nuclei with DAPI (blue staining). Lumio-
tagged protein expression in the lentivirus-infected HaCaT cells in
monolayer culture was detected using the Lumio Green In-Cell
Labeling Kit (Invitrogen).
Immunohistochemistry
For IHC analysis, 6-mm punch biopsies were taken from the
LSE cultures, split in half, and fixed in neutral-buffered formalin
for 3 hours, transferred to 70% ethanol, processed, and embedded
in paraffin, and sectioned for IHC (service purchased from
AML Labs, Baltimore, MD). Sections were deparaffinized, antigen
retrieval was performed by boiling for 5minutes in 10mM sodium
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citrate, pH 6.1. IHC was performed using the Superpicture IHC
kit (Invitrogen). Primary antibodies were used following the
manufacturers’ instructions and tested for best dilution. Slides
were counterstained with hematoxylin and mounted for viewing
and imaging with Clearmount water-soluble mounting medium
(Invitrogen).
Western blotting
For western blotting, the epidermis was dissolved in 8M urea
containing 50mM Tris-HCl, pH 7.4, 10mM EDTA, and 1% TritonX-
100. The nonsoluble residue was separated through centrifugation.
The protein concentration was adjusted to 1mg ul1 after the protein
assay, carried out from the supernatant using Quick Start Bradford
Dye Reagent (BioRad, Hercules, CA) and a QuickStart BSA Standard
Set (BioRad). Ten micrograms of protein, after mixing with 2
Laemmli sample buffer (BioRad) with b-ME and heat denaturation at
95 1C for 15minutes, was separated through a 4–20% PAGE
(Criterion Tris-HCl gels, 26 wells, BioRad). After transfer, the PVDF
membrane was blocked at room temperature for at least 1 hour in
PBS containing 1% BSA, and incubated at þ 8 1C overnight with
primary antibodies diluted in PBS containing 1% BSA. The
membrane was further washed three times with TBST (Tris Buffered
Saline, Sigma), incubated at room temperature for 1.5 hours with
Cy5-conjugated secondary antibody (Cy5-conjugated AffiniPure
Anti-Mouse or Anti-Rabbit IgG, Jackson ImmunoResearch) diluted
1:1,000 in PBS containing 1% BSA, and then washed with three
changes of TBST, and scanned with Licor-Odyssey at 700 channel.
As a molecular mass marker, a broad-range Precision Plus Protein
Dual Color Standard (BioRad) was diluted 1:5 in Laemmli sample
buffer and 10 ml was loaded per well, which was visible with the 700
channel in Licor scanning.
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